Literature DB >> 4605004

R-factor-mediated beta-lactamases that hydrolyze oxacillin: evidence for two distinct groups.

J W Dale, J T Smith.   

Abstract

The enzymatic and molecular properties of 14 oxacillin-hydrolyzing beta-lactamases, all of them R-factor-specified, were studied, and two distinct groups were found. Four of the enzymes had a molecular weight of 24,000, were active against methicillin, and had an electrophoretic mobility of -0.1 cm/h. Eight enzymes had a molecular weight of 45,000, low activity against methicillin, and an electrophoretic mobility of +0.5 cm/h. The remaining two enzymes were similar to those of the second group in being relatively inactive against methicillin, but their molecular weight was lower (42,000) and their electrophoretic mobility was different (-0.1 cm/h). All the enzymes of both groups were sensitive to inhibition by sodium chloride. The two groups were not completely homogeneous in their enzymatic properties; seven possible subtypes could be recognized.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4605004      PMCID: PMC245614          DOI: 10.1128/jb.119.2.351-356.1974

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  21 in total

Review 1.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

2.  High level transferable resistance to gentamicin.

Authors:  J L Witchitz; Y A Chabbert
Journal:  J Antibiot (Tokyo)       Date:  1971-02       Impact factor: 2.649

3.  Separation of blood coagulation factors II, VII, IX and X by gel filtration in the presence of dextran blue.

Authors:  A C Swart; H C Hemker
Journal:  Biochim Biophys Acta       Date:  1970-12-29

4.  Purification and properties of glutathione reductase of human erythrocytes.

Authors:  G E Staal; J Visser; C Veeger
Journal:  Biochim Biophys Acta       Date:  1969-07-08

5.  A direct comparison of two unusual R-factor-mediated -lactamases.

Authors:  J W Dale; J T Smith
Journal:  Biochem J       Date:  1972-06       Impact factor: 3.857

6.  The purification and properties of penicillin beta-lactamases mediated by transmissible R factors in Escherichia coli.

Authors:  S Yamagishi; K O'Hara; T Sawai; S Mitsuhashi
Journal:  J Biochem       Date:  1969-07       Impact factor: 3.387

7.  Characterization of the -lactamase specified by the resistance factor R-1818 in E. coli K12 and other Gram-negative bacteria.

Authors:  J W Dale
Journal:  Biochem J       Date:  1971-07       Impact factor: 3.857

8.  Some relationships between R-factor and chromosomal -lactamase in Gram-negative bacteria.

Authors:  J W Dale; J T Smith
Journal:  Biochem J       Date:  1971-07       Impact factor: 3.857

9.  The purification and properties of the -lactamase specified by the resistance factor R-1818 in Escherichia coli and Proteus mirabilis.

Authors:  J W Dale; J T Smith
Journal:  Biochem J       Date:  1971-07       Impact factor: 3.857

10.  -lactamases of R factors derived from Shigella and Salmonella strains.

Authors:  P H Jenkins; W T Drabble
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

View more
  35 in total

1.  Analytical isoelectric focusing of R factor-determined beta-lactamases: correlation with plasmid compatibility.

Authors:  M Matthew; R W Hedges
Journal:  J Bacteriol       Date:  1976-02       Impact factor: 3.490

2.  Plasmid-determined beta-lactamase indistinguishable from the chromosomal beta-lactamase of Escherichia coli.

Authors:  M M Bobrowski; M Matthew; P T Barth; N Datta; N J Grinter; A E Jacob; P Kontomichalou; J W Dale; J T Smith
Journal:  J Bacteriol       Date:  1976-01       Impact factor: 3.490

3.  OHIO-1 beta-lactamase is part of the SHV-1 family.

Authors:  D M Shlaes; C Currie-McCumber; A Hull; I Behlau; M Kron
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 4.  Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

5.  In vitro studies on the antibacterial activities of YM-13115, a new broad-spectrum cephalosporin.

Authors:  M Toda; N Arao; C Nohara; K Susaki; A Tachibana
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

6.  What do beta-lactamases mean for clinical efficacy?

Authors:  H C Neu
Journal:  Infection       Date:  1983       Impact factor: 3.553

7.  Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.

Authors:  D J Payne; R Cramp; D J Winstanley; D J Knowles
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Beta-lactamase-directed barrier for penicillins of Escherichia coli carrying R plasmids.

Authors:  T Yamamoto; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

9.  Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

10.  Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.

Authors:  H Matsui; M Hiraoka; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.